Article Details

AstraZeneca's Imfinzi combo gets FDA approval for advanced biliary tract cancer

Retrieved on: 2022-09-05 09:43:45

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Imfinzi combo gets FDA approval for advanced biliary tract cancer. View article details on hiswai:

Excerpt

The the Food and Drug Administration ((FDA)) approved AstraZeneca's (AZN) Imfinzi (durvalumab), in combination with chemotherapy (gemcitabine plus ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up